INTRODUCTION
In all eukaryotes and vertebrate tissues studied thus far, AMP deaminase (EC 3.5.4.6) catalyses the essentially irreversible hydrolytic deamination of 5'-AMP to yield equimolar amounts of 5'-IMP and ammonia [1] . Of the multiple tissue-specific isoforms identified in mammals, skeletal-muscle AMP deaminase has been the most extensively investigated, a reflection of the very high AMP deaminase activity in this tissue [2] and the inherited AMP deaminase deficiency noted in -20% of all human skeletalmuscle biopsies [3] . In response to increased work demand, skeletal-muscle AMP deaminase supplies the purine nucleotide cycle with IMP critical to adenylate restoration after exertion [4] . Other important functions proposed for AMP deaminase in skeletal muscle include stabilization of energy charge [5] and indirect modulation of AMP-sensitive metabolic pathways [6] .
The very limited activity of the purine nucleotide cycle in welloxygenated working heart [7] suggests that cardiac AMP deaminase might assume greater significance under injury conditions which elicit myocardial ATP loss. In this regard, cardiac AMP deaminase may modulate the purine nucleotide and nucleoside catabolism characteristic of ischaemic heart disease [8] . Elevated levels of cardiac-tissue IMP found in some experimental models ofmyocardial ischaemia [9] [10] [11] offer indirect evidence for an ischaemia-related enhancement of flux through cardiac AMP deaminase. Furthermore, IMP production in muscle cells isolated from the rat heart and rapidly de-energized by metabolic poisons is potentiated by ax-adrenergic stimulation [12] and the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate [13] , suggesting that cardiac AMP deaminase activity may be modulated by phosphorylation-dependent reactions. This suggestion gains particular interest through recent reports linking myocardial ischaemia with PKC activation [14, 15] . GTP, which decreased the Vmax by -50 % in each case. PKCdependent phosphorylation of cardiac AMP deaminase did not alter the enzyme's allosterism toward millimolar ATP or ADP: both nucleotides at 1.0 mM concentration decreased the apparent Km to -0.5 mM. Treatment of cardiac phospho-AMP deaminase with either the protein phosphatase calcineurin or alkaline phosphatase generated a dephosphorylated form which displayed molecular and kinetic properties identical with those of the originally isolated enzyme. These data raise the possibility that a phosphorylation-dephosphorylation mechanism may regulate flux through AMP deaminase in the heart under pathological conditions, such as myocardial ischaemia, characterized by PKC activation and adenylate depletion.
We report here the ability of mammalian cardiac AMP deaminase to undergo kinase-mediated phosphorylation and the effects of this covalent modification on enzyme activity. Our results constitute direct demonstration that phosphorylation of cardiac AMP deaminase specifically by PKC can modulate enzyme activity by markedly increasing the apparent affinity of this AMP deaminase isoform for substrate. The data have implications regarding the regulation of AMP deaminase in the mammalian heart and its potential role in catalysing adenylate degradation during myocardial ischaemia. (Figure 1 ) [16, 17] .
EXPERIMENTAL

Phosphorylation of AMP deaminase
Phosphorylation of AMP deaminase by the catalytic subunit of protein kinase A was assayed as modified from Corbin and Reimann [18] in the presence of (final concns.) 50 mM Tris maleate (pH 7.0), 10 mM MgCl2, 10 mM KCl, 1 mM EGTA, 10 IaM ATP (2) (3) (4) (5) ,uCi of [y-32P]ATP) and 5 units/ml catalytic subunit of protein kinase A (sp. activity 41 units/,tg). After a 15 min incubation at 30°C, the reaction was terminated either with Laemmli buffer for subsequent SDS/PAGE analysis [19] or with trichloroacetic acid (final concn. 20 %, w/v) for quantitative determination of 32P incorporation into the washed acid-precipitable protein pellet.
Phosphorylation of AMP deaminase by cGMP-dependent protein kinase was assayed as described [20] in the presence of (final concns.) 50 mM Hepes/KOH (pH 7.5), 10 mM MgCl2, 0.2 mM EGTA, 10 ,tM ATP (2-5 ,uCi of [y-32P]ATP), 5 units/ml cGMP-dependent protein kinase (sp. activity 2400 units/,tg) and 0.5 ,tM cGMP. After incubation for 15 min at 30 'C, the reaction was terminated with either Laemmli buffer or trichloroacetic acid, for processing as described above.
Phosphorylation of AMP deaminase by Ca2+/calmodulindependent protein kinase was assayed in the presence of 50 mM Tris/HCl (pH 8.0), 10 and 30 ,tg/ml calmodulin (sp. activity 1000 units/mg) [21] . Reactions were conducted at 30°C for 15 min and processed as described above.
Phosphorylation of AMP deaminase by PKC was studied in the reaction system of Yasuda et al. [22] in the presence of (final concns.) 50 mM Hepes/KOH (pH 7.0), 10 260 ,ug/ml phosphatidylserine, 40 ,ug/ml 1,2-diolein, 20 nM phorbol 12-myristate 13-acetate and 1 unit/ml PKC (sp. activity 1900 units/mg). After incubation for 15 min at 30°C, the reaction was terminated and processed for analysis as described above.
Dephosphorylation of phospho-AMP deaminase
Dephosphorylation reactions were performed with minor modifications of methods detailed [23] . Samples were treated with 0.5 unit/ml (final concn.) ATPase (sp. activity 1.1 units/mg) to remove any residual ATP from the PKC reaction. Phospho-AMP deaminase was incubated in 50 mM Hepes/KOH buffer (pH 7.0) in the presence of (final concns.) 2 units/ml calcineurin (sp. activity 4500 units/mg), 5 mM CaCl2 and 1 ,uM calmodulin at 30°C for 2 h. Alternatively, the phosphoenzyme was incubated in 50 mM Na2B407/NaOH buffer (pH 9.5) with 2.5 units/ml alkaline phosphatase (final concn.; sp. activity 2500 units/mg) at 30°C for 2 h. In both cases, reaction samples were analysed for AMP deaminase activity and processed for SDS/PAGE and autoradiography (see below).
Electrophoresis and autoradiography SDS/PAGE was performed as described by Laemmli [19] in 10 0,-polyacrylamide slab gels. Samples were prepared for SDS/PAGE in Laemmli buffer [19] . After electrophoresis, gels were stained with Coomassie Brilliant Blue G-250, dried, and exposed to Kodak XAR-2 film overnight at -80°C for autoradiography. The film was then developed in an automated processor.
AMP deaminase assay and determination of kinetic constants AMP deaminase was assayed as ammonia formation in 50 mM imidazole/HCl buffer (pH 6.8) containing (final concns.) 100 mM KCl and 5 mM 5'-AMP. The reaction was initiated upon substrate addition and performed at 30°C for up to 5 min in a shaking water bath, during which time samples were taken for measurement of ammonia formation [16, 17] . Ammonia was quantified by using phenol/hypochlorite [24] . For all AMP deaminase assays, a first-order relationship among reaction time, protein concentration and enzyme activity was maintained. Apparent kinetic constants (Ki, Vmax) were derived from Lineweaver-Burk transformations [25] of AMP deaminase reaction velocity as a function of substrate concentration.
RESULTS
AMP deaminase purified to electrophoretic and chromatographic homogeneity from left-ventricular rabbit myocardium was used throughout these studies (Figure 1 ) [16, 17] . As analysed by SDS/PAGE followed by autoradiography, cardiac AMP deaminase became rapidly phosphorylated when incubated with PKC and [y-32P]ATP, provided that the requisite cofactors for PKC activity were also present (Figure 1 ). PKC-mediated phosphorylation of rabbit heart AMP deaminase was linearly dependent on the PKC and AMP deaminase contents of the reaction system over time (Figure 2 Figure 3 Lineweaver-Burk plots for rabbit heart AMP deaminase before Table 1 Nucleotide effectors and phosphorylation state of rabbit heart and after PKC-dependent phosphorylation AMP deaminase
The substrate-concentration-dependence of the reaction rate of cardiac AMP deaminase, either as isolated from rabbit myocardium (@) or as isolated and then phosphorylated in vitro by PKC (E), is given here in a Lineweaver-Burk transformation. Data for phospho-AMP deaminase, after dephosphorylation by calcineurin, are also given (0). Each data point is the mean of at least three independent determinations; the range about each mean is < 10%. reaction containing 25 ,ug of AMP deaminase and 80 m-units of PKC. These data allow estimation that approx. 1 phosphate molecule is incorporated per holoenzyme. Inclusion of staurosporine, a potent PKC inhibitor [26] , at a final concentration of 10 nM blocked the PKC-mediated phosphorylation of rabbit heart AMP deaminase (Figure 2 
DISCUSSION
Ischaemia may elicit cardiac IMP formation [9, 10] , and the standard PKC activator phorbol 12-myristate 13-acetate potentiates IMP production in cardiomyocytes de-energized with metabolic poisons [13] . These results have led to speculation that mammalian cardiac AMP deaminase activity may be modulated by post-translational phosphorylation [13] . Such speculation, however, was advanced despite the variable association between myocardial ischaemia and ATP degradation to IMP [11] . Furthermore, ATP depletion in poisoned cardiomyocytes is much faster than during ischaemia/anoxia, and involves bioenergetic derangements (e.g. mitochondrial uncoupling) not necessarily found in acute myocardial ischaemia [8] . There is also a conspicuous lack of any evidence that the cardiac isoform of mammalian AMP deaminase serves as a substrate for protein kinases.
Our studies provide compelling demonstration that rabbit heart AMP deaminase can be phosphorylated rapidly and specifically by PKC, thereby activating the enzyme through a marked (-5-fold) increase in the apparent affinity of the cardiac isoform for AMP substrate. Phosphorylation of AMP deaminase by PKC was observed only in the presence of PKC cofactors. Neither the allosterism of cardiac AMP deaminase toward ATP and ADP nor its inhibition by GTP was altered by PKCdependent phosphorylation. As a whole, these data imply that activation of cardiac AMP deaminase by PKC does not occur through phosphorylation at an allosteric nucleotide-binding site and support a molecular mechanism involving enhancement of substrate affinity through phosphorylation of active-site amino acid residue(s), as has been observed for some other enzymes of intermediary metabolism [28] .
Rat skeletal-muscle AMP deaminase has been reported to serve as a PKC substrate, its apparent Km decreasing from 0.6 mM AMP to 0.2 mM AMP upon phosphorylation [29] . Thus the Km of 1.2 mM for cardiac phospho-AMP deaminase indicates that PKC-dependent phosphorylation brings its substrate affinity near the 0.3-0.7 mM Km range reported for various skeletalmuscle AMP deaminase isoforms [30, 31] . With allosteric activation by 1.0 mM ATP or ADP, cardiac phospho-AMP deaminase displays a Km equivalent to that of the skeletalmuscle isoform. However, the Vmax of rabbit heart AMP deaminase, whether phosphorylated or not, remains -100-fold lower than reported V,nax values > 1000 1tmol/min per mg for the rabbit skeletal-muscle enzyme [1, 32] . The Dephosphorylation of rabbit heart phospho-AMP deaminase generated an enzyme with molecular and kinetic properties identical with those of the AMP deaminase isolated from the non-ischaemic source tissue, and neither phosphatase treatment nor the presence of the potent phosphatase inhibitor okadaic acid during the isolation affected the properties of AMP deaminase purified from rabbit heart. These findings imply that healthy myocardium contains predominantly nonphosphorylated AMP deaminase of low substrate affinity. They also suggest a mechanism whereby phosphorylationdephosphorylation of cardiac AMP deaminase in situ could regulate its contribution to tissue adenylate depletion. The marked decrease in the Km of cardiac AMP deaminase upon PKC-dependent phosphorylation and the further allosteric decrease in the Km of phospho-AMP deaminase by ADP would imply that such a regulatory mechanism might act as a pathophysiologically important enhancer of flux through AMP deaminase during disease states, such as myocardial ischaemia, involving ATP degradation [8] . The concept of an ischaemiarelated activation of cardiac AMP deaminase through direct PKC-dependent phosphorylation gains attractiveness from the PKC activation observed during acute myocardial ischaemia [15, 33] . Although the mechanisms by which PKC is activated during myocardial ischaemia are not well understood [15] 
